R&D Systems™ Recombinant Human PILR-alpha Fc Chimera Protein

Catalog No.	Quantity
10802PR050	50 μg

Catalog No. 10802PR050 Supplier R&D Systems™ Supplier No. 10802PR050

Description

Recombinant Protein

Measured by its binding ability in a functional ELISA. When Recombinant Human PANP Fc Chimera (Catalog # 7920-PN ) is coated at 5.00 μg/mL (100 μL/well), Recombinant Human PILR-alpha Fc Chimera binds with an ED50 of 0.150- 0.900 μg/mL.

Specifications

• Accession Number: Q9UKJ1.3
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
• Gene ID (Entrez): 29992
• Molecular Weight (g/mol): M.W.-observed: 57-64 kDa, under reducing conditions, M.W.-theroretical: 46 kDa
• Quantity: 50 μg
• Source: Chinese Hamster Ovary cell line, CHO-derived human PILR-alpha protein Human PILR-alpha (Thr25-Thr196) (N-terminus) Accession # Q9UKJ1.3 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU / 1 μg of the protein by the LAL method.
• Gene Alias: Cell surface receptor FDF03, FDF03, inhibitory receptor PILRalpha, Inhibitory receptor PILR-alpha, paired immunoglobin-like receptor alpha, paired immunoglobin-like type 2 receptor alpha, paired immunoglobulin-like receptor alpha, paired immunoglobulin-like type 2 receptor alpha, PILRA, PILRalpha
• Conjugate: Unconjugated
• Reconstitution: Reconstitute at 500 μg/mL in PBS.
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.
• Protein: PILR-alpha